Since the discovery of penicillin, antibiotics have radically transformed medicine. But the overuse of these medicines has led to the emergence of drug-resistant strains. Today, the search for new products is lagging behind, as shown by an analysis by Charalampos Valmas, Globaldata's expert on infectious diseases. 
According to the analyst, the 'escape' of Big Pharma from this sector has left important room for maneuver to small biotech companies. But there is also a clear strategy to attract Big Pharma giants back into this business. And thus facilitate the development
